News | Atrial Fibrillation

May 15, 2018 — According to new research, smoking marijuana may not be associated with an increased risk of ventricular ...

Home May 15, 2018
Home
News | Interventional Radiology

U.S. First Lady Melania Trump underwent an interventional radiology embolization procedure to treat a benign kidney condition, according to a statement from the White House Press Office.

Home May 15, 2018
Home
News | Atrial Fibrillation

May 15, 2018 – Results of the AVIATOR 2 international registry data show a discrepancy between physician perception and ...

Home May 15, 2018
Home
News | Peripheral Artery Disease (PAD)

The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to address the selection of specific categories of devices when endovascular therapy (EVT) is indicated. The purpose of this document, which is the first of its kind, is to provide a review of comparative effectiveness data, including safety and efficacy of femoral-popliteal (FP) devices. The document also provides clinicians with guidance and recommendations for device selection when these devices are intended as the definitive or adjunctive therapy.

Home May 15, 2018
Home
News | Cath Lab

Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary intervention (PCI) will allow for flexibility in length of stay while ensuring patient safety. The guidelines were published in early-view online in Catheterization and Cardiovascular Interventions, the official journal of the Society for Cardiovascular Angiography and Interventions (SCAI).

Home May 15, 2018
Home
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab

May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal ...

Home May 15, 2018
Home
News | Cath Lab

May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used ...

Home May 15, 2018
Home
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018
Feature | Cardiovascular Clinical Studies

May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin ...

Home May 14, 2018
Home
A 3-D printed aortic root with an simulated implant of an Edwards Sapien TAVR valve. New clinical data points to length-of-stay as a new predictor of outcomes in TAVR patients. Image from Henry Ford Hospital.
Feature | Heart Valve Technology

May 14, 2018 – A new study finds patients who stay in the hospital for more than 72 hours when undergoing trans-femoral ...

Home May 14, 2018
Home
News | Chronic Total Occlusion (CTO)

May 14, 2018 – One-year outcomes of patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention ...

Home May 14, 2018
Home
News | Heart Valve Technology

May 14, 2018 – A new study examines the effectiveness of 3-D printing technology and computer modeling to predict ...

Home May 14, 2018
Home
News | Peripheral Artery Disease (PAD)

The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the SCAI PAD Diagnosis and Treatment Resource Center. This center will be an ongoing, patient-centered quality improvement initiative focused on helping increase peripheral artery disease (PAD) awareness in the cardiovascular and internal medicine community by delving into the underlying risks of this disease state.

Home May 14, 2018
Home
News | Chronic Total Occlusion (CTO)

May 14, 2018 — A significant update to the PROGRESS-CTO (PROspective Global Registry for the Study of Chronic Total ...

Home May 14, 2018
Home
News | Cardiovascular Clinical Studies

May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients ...

Home May 14, 2018
Home
Richard Schatz, M.D., (center) is research director of cardiovascular interventions at the Heart, Lung, and Vascular Center at Scripps Clinic, speaking at a SCAI session on collaboration with industry to bring new device technologies to market. He is best known as the co-inventor of the first coronary stent, the Palmaz-Schatz stent. Left is Ziyad Hijazi, M.D., MPH, director of the Sidra Cardiac Program. #SCAI, #SCAI2018
Feature | SCAI

Here is an aggregation of all the news and late-breaking studies presented at the 2018 Society for Cardiovascular ...

Home May 14, 2018
Home
Subscribe Now